How has the Rising Usage of Cannabis in the Medicinal Field Resulted in the Expansion of Legal Cannabis Market?
The market is predicted to flourish because of the accelerating rate of legalization of cannabis and acceptance of its usage in the medicinal field. Cannabis has traditionally been used medicinally, but not as the first line of defense. Cannabis has been utilized for a variety of reasons as a result of research into its therapeutic effects. Cannabis has been discovered to be quite beneficial as a treatment for chronic pain and nausea produced by chemotherapy. The cannabis industry in the United States is predicted to generate $32 billion in yearly sales by 2022. Medical hemp has recently received a great deal of worldwide attention. Medical C. Sativa use and acceptability continue to expand, as seen by an increasing number of countries and jurisdictions allowing its use for particular medical purposes.
Furthermore, because of the therapeutic benefits of marijuana, countries such as Germany, Finland, Israel, and Canada have taken unprecedented moves to legalize its usage for medical purposes. Over 25 states in the United States have amended their laws to legalize cannabis for medical use. In California and Florida, mainstream doctors have successfully used the substance to treat AIDS, anorexia, arthritis, and even cancer. The industry has grown as the legalization and legitimization of medicinal cannabis has steadily increased. As the demand for medical cannabis grows, so do government-approved and sanctioned purchasing choices. The FDA has approved CBD products containing medical cannabis to treat epilepsy seizures and chemotherapy-induced nausea. The continuing research and clinical studies for many Cannabis-based therapies are projected to further fuel market expansion in the future.
What is the Market Size of Legal Cannabis in terms of value?
The Global Legal Cannabis Market is projected to increase at a significant CAGR of 25.20 % in the coming years. In 2021, the global Legal Cannabis market was valued at USD 12.9 billion and is projected to reach the value of USD 49.7 billion by 2028. Therefore, the demand for Legal Cannabis is projected to increase substantially in the coming years and is presumed to generate revenue opportunities for the key industry players worth USD 36.8 billion in the period between 2022 and 2028.
What are the Various Pandemic and Post-Pandemic COVID-19 Effects on the Legal Cannabis market?
During the pandemic, From 2019 to 2020, the legal cannabis market dropped by 29.6 %. The main reason for the drop in total revenue was the government-imposed prohibition on cross-border trade owing to the ongoing pandemic. In addition, consumers were storing owing to concerns about the scarcity of cannabis and associated products. The entire market has grown as the number of customers has increased, but prices have fallen, and there has been illegal trade as a result of the pandemic. However, in the next five years, the market is expected to rise by 25% to 30% year on year because of the stigma associated with cannabis usage in most parts of the world; the market already has fewer participants. The pandemic has resulted in an increase in the number of users. The FDA has various guidelines in place, and new rules are being developed to legalize and regulate cannabis use. As a result, the entire market is likely to expand gradually in the future years.
Interesting Facts about Legal Cannabis Industry
- The market is expected to grow due to the increasing rate of cannabis legalization and acceptance of its use in the healthcare profession. The sector has grown as the legalization and validity of cannabis for medical purposes has steadily increased.
- The North America region had a major share in terms of volume as well as value in the global Legal Cannabis market in 2021 and is projected to dominate the market over the forecast period.
- During the pandemic, CBD sales took a new direction. Dispensaries selling CBD products were declared vital in more than eight states in the United States, numerous states legalized cannabis throughout the epidemic, and sales continued to rise.
- Companies are expanding their product ranges as well as expanding through mergers and acquisitions of small industry competitors. Moreover, cannabis for medicinal reasons has grown in popularity, and various governments worldwide are developing rules for its usage and distribution.
Who are the Top 10 Players/Companies in the Legal Cannabis market in terms of value?
The key players in the global Legal Cannabis market in terms of value Canopy Growth Corporation; Aurora Cannabis; Aphria, Inc.; Tilray; Maricann Group, Inc.; Organigram Holding, Inc.; Lexaria Corp.; GW Pharmaceuticals; ABcann Medicinals, Inc.; The Cronos Group; United Cannabis Corporation; and Tikun Olam, Ltd. These key players are concentrating on new product developments as well as technological innovation to enhance their production in Legal Cannabis to gain competitive market share at a global level. For instance, in April 2021, Canopy Growth Corporation and The Supreme Cannabis Company, Inc. announced that they have reached a binding agreement for the former to acquire the latter. This acquisition will help the company extend not only its product offering but also strengthen its market position. On the other hand, in March 2021, Mexican senators backed a bill legalising recreational cannabis, a watershed moment in the country's drug battle that might lead to it becoming the world's largest market. With permission, adults would be able to smoke marijuana and grow a limited number of plants at home. It also grants manufacturers permission to cultivate and sell the crop.
Who are the Top 10 Countries in the Legal Cannabis Market?
The major countries in the global Legal Cannabis market are US, Canada, Ukraine, China, Russia, India, Africa, Australia, Spain, and Czech Republic. The largest market share is in the United States. Cannabis is now legal in the United States for both medical and recreational purposes. Cannabis has been discovered to be quite helpful as a pain reliever and in relieving nausea produced by chemotherapy. Despite the fact that it is still categorized as a Schedule I narcotic by the United States Drug Enforcement Administration (DEA), it is lawful in more than two-thirds of the states. CBD for medical purposes has grown in popularity, and numerous governments around the United States are developing rules for its use and delivery. Legalization has increased the number of jobs in the industry and promoted market growth. According to New Frontier Data, the legal marijuana sector in the United States was valued at $13.6 billion in 2019, with 340,000 employment devoted to plant care.
Which is the Key End Use Segment in the Legal Cannabis Market?
The medical-use segment accounts for the majority of revenue. Several research are being undertaken to determine the potency and effectiveness of cannabis and its derivatives for the treatment of different illnesses, which has led to an increase in the global usage of medical cannabis. Legalization has also played an important role in industry expansion. The medical use application has received widespread acceptance, and so constitutes the largest sub-segment. Moreover, with governments enacting norms and regulations governing its usage, medical practitioners are finding it easier to prescribe to patients who request it. The stigma associated with cannabis use has been greatly lessened as more people become aware of its benefits.
What are the Major Driving Factors for Legal Cannabis Market?
The increasing rate of legalization of cannabis and approval of its use in the healthcare profession are the major factors due to which the market is anticipated to rise. The sector has expanded as a result of a steady increase in the legalization and legitimacy of cannabis for medical purposes. The demand for medical cannabis is booming, and so are the number of authorized and certified purchase choices. The FDA has approved CBD-based medical cannabis products for treating chemotherapy-induced nausea and epilepsy seizures. Cannabis and its derivatives have seen a sharp rise in popularity in recent years. The use of CBD for medical purposes has grown significantly in popularity, and numerous governments worldwide are developing regulations for its distribution and use.What are the Major Restraints for Legal Cannabis Market?
One of the key challenges impeding market expansion is the complex regulatory structure for usage. Companies that sell cannabis and cannabis-infused goods must follow various regulatory rules worldwide. As a result, manufacturers and stakeholders may find it difficult to comply with the tight regulatory rules governing manufacturing and sales in different nations. Furthermore, because the legislation governing cannabis use differ from country to country, the global cannabis business faces additional challenges.
Which Region Dominated the World Legal Cannabis Market?
In 2021, North America dominates the Legal Cannabis market over the forecast period due to rules and regulations governing the commerce of cannabis; revenue is highly regional. North America is the region with the most market shareholders because many established corporations exist. GW Pharmaceuticals, Cronos Group, GrowGeneration, Green Thumb Industries, Innovative Industrial Properties, Trulieve Cannabis, Creso Labs, Columbia Care, and Curaleaf Holdings are some of the major players in the industry. The total regional market has grown as a result of rising consumer demand; accelerated legalization could also be a contributing factor. Cannabis and its derivatives have seen a sharp rise in popularity in recent years. The use of CBD for medical purposes has grown significantly in popularity, and numerous governments worldwide are developing regulations for its usage and distribution in Canada. In 2020, 14% of participants who were 16 years old or older said they used cannabis for medical purposes. According to data from the CCS 2020, legalization has reduced black market sales. The majority of medical cannabis in Canada was bought from stores that were legally authorized to sell it, and the proportion of purchases made from unlicensed or illegal sources has decreased.
Asia is the region with the fastest expanding market for cannabis despite stringent legal restrictions on its use and possession. This may be a result of cannabis becoming more widely accepted in the region's various nations. Another important factor influencing the local market is the volume of clinical studies on cannabis' potential benefits for treating a wide range of medical problems. The use of medical cannabis and industrial purposes is becoming more common throughout Asia, but recreational usage is still generally frowned upon. Clinical trials for CBD compounds have been authorized in Japan. However, due to the country's rapidly aging population, possession of recreational cannabis is still a crime that can result in a five-year prison sentence. Cannabis growing has risen for the manufacture of CBD for therapeutic uses since 2019. Growth in manufacturing and export revenue might also boost the regional market.
Segmentation of Global Legal Cannabis Market-
Global Legal Cannabis Market – By Product Type- Flower
- Oil and Tinctures
- Medical
- Adult Use
Request a Free Sample
Fill in your details and we'll send you a free sample report.
- Sample data tables & charts
- Research methodology
Need a Custom Version of This Report?
Tailor the scope, geography, or segments to your exact requirements.
- Custom geography or segment scope
- Direct access to our analyst team
Frequently Asked Questions
How does COVID-19 Impact the global Legal Cannabis market?
Which is the leading market for Legal Cannabis?
What are the key drivers for the growth of the Legal Cannabis market?
Which is the major product type segment in the Legal Cannabis Market by drugs by route of administration?
Which is the major application segment in Legal Cannabis Market by molecule type?
Table of Content
Chapter 1. Report Introduction
- 1.1 Report Description & Purpose
- 1.1.1 Report Title & Market Definition
- 1.1.2 Unique Selling Propositions (USP) & Key Differentiators
- 1.1.3 Value Proposition for Stakeholders
- 1.2 Research Objectives
- 1.2.1 Market Sizing Objectives (Volume & Revenue) (Volume Where Applicable)
- 1.2.2 Segmentation Objectives
- 1.2.3 Competitive Intelligence Objectives
- 1.2.4 Forecast & Scenario Objectives
- 1.3 Report Scope
- 1.3.1 Legal Cannabis Scope – Segments & Subsegments Covered
- 1.3.2 Geographic Scope – Regions & Countries Covered
- 1.3.3 Historical Period, Base Year & Forecast Period (2028; forecast to the forecast period)
- 1.3.4 Inclusions & Exclusions
- 1.4 Industry Classification & Applicable Codes
- 1.5 Currency, Measurement Units & Valuation Basis
- 1.6 Target Stakeholders
- 1.7 Limitations & Assumptions
Chapter 2. Executive Summary
- 2.1 Global Legal Cannabis Market Snapshot
- 2.1.1 Market Size – Historical (2028) & Forecast (the forecast period) (2028: USD 81,100.73 million → forecast year: USD 296,611.01 million)
- 2.1.2 Volume & Revenue – Global Totals (Volume Where Applicable)
- 2.1.3 Key Market Highlights – Top Five Facts
- 2.2 Legal Cannabis Market Segmentation Snapshot
- 2.2.1 Market Split by Region – 2028 vs.
- 2.3 Competitive Snapshot
- 2.3.1 Top 10 Players by Revenue Share – 2028
- 2.3.2 Top 10 Players by Volume Share – 2028 (Volume Where Applicable)
- 2.3.3 Recent Strategic Developments (18-Month Summary)
- 2.4 Key Investment Highlights & Strategic Conclusions
Chapter 3. Legal Cannabis Market Dynamics & Industry Analysis
- 3.1 Market Overview & Context
- 3.1.1 Legal Cannabis Market Position in the Broader Industry Value Chain
- 3.1.2 Demand Structure & Purchasing Dynamics
- 3.1.3 Market Maturity & Development Stage by Region
- 3.2 Legal Cannabis Market Drivers
- 3.3 Legal Cannabis Market Restraints & Challenges
- 3.4 Legal Cannabis Market Opportunities
- 3.5 Porter's Five Forces Analysis
- 3.5.1 Threat of New Entrants
- 3.5.2 Bargaining Power of Suppliers
- 3.5.3 Bargaining Power of Buyers
- 3.5.4 Threat of Substitutes
- 3.5.5 Competitive Rivalry – Intensity Assessment
- 3.6 Legal Cannabis Value Chain Analysis
- 3.6.1 Upstream – Key Inputs, Resources & Suppliers
- 3.6.1.1 Key Input/Resource 1
- 3.6.1.2 Key Input/Resource 2
- 3.6.1.3 Key Input/Resource 3
- 3.6.2 Midstream – Core Operations & Value Creation
- 3.6.2.1 Operating Model & Process Overview
- 3.6.2.2 Key Operating Locations & Capabilities by Company
- 3.6.3 Downstream – Market Channels & End Users
- 3.6.3.1 Direct Sales & Customer Engagement Channels
- 3.6.3.2 Indirect Sales, Intermediaries & Partner Channels
- 3.6.4 Value Chain Profitability Analysis
- 3.6.1 Upstream – Key Inputs, Resources & Suppliers
- 3.7 PESTEL Analysis
- 3.7.1 Political Factors
- 3.7.2 Economic Factors
- 3.7.3 Social Factors
- 3.7.4 Technological Factors
- 3.7.5 Environmental Factors
- 3.7.6 Legal Factors
- 3.8 Legal Cannabis Supply Chain Analysis
- 3.8.1 Critical Input & Resource Availability Risk Assessment
- 3.8.2 Supplier & Operational Concentration Risk (Geographic Exposure)
- 3.8.3 Supply & Service Disruption Impact Analysis
- 3.9 Regulatory & Policy Landscape
Note: The regulatory and policy landscape section covers regulations based on their applicability to the market, Legal Cannabis category, geography, and scope of the study. Only regulatory frameworks with a material impact on operations, compliance, trade, sustainability, or market access are analyzed in detail.
Chapter 4. Key Investment Pockets & Opportunity Analysis
- 4.1 Legal Cannabis Market Attractiveness Analysis
- 4.1.1 By Region – Investment Attractiveness Matrix (Market Size × CAGR)
- 4.2 Absolute Revenue Growth Opportunity
- 4.2.1 By Region – Absolute Revenue Growth Through the forecast period
- 4.3 Incremental Demand Opportunity
- 4.3.1 By Region – Incremental Demand Through the forecast period
- 4.3.2 Segment – Incremental Demand
- 4.4 Emerging Submarket Opportunity Deep Dive (Subject to Applicability)
- 4.5 Priority Market Opportunity Scorecards
- 4.5.1 United States
- 4.5.2 Europe
- 4.5.3 Asia
- 4.5.4 Middle East & Africa
Note: Priority market opportunity scorecards reflect the geographic scope and strategic relevance of the study. Listed markets are indicative and may be adapted to the industry.
Chapter 5. Legal Cannabis Cross-Border Trade & Market Access Analysis
- 5.1 International Trade & Cross-Border Activity Overview
- 5.1.1 Global Export Value by Country (2028)
- 5.1.2 Global Export Volume by Country (2028) (Volume Where Applicable)
- 5.1.3 Global Import Value by Country (2028)
- 5.1.4 Global Import Volume by Country (2028) (Volume Where Applicable)
- 5.1.5 Net Trade Balance by Country (2028)
- 5.2 Export Analysis – Segment
- 5.2.1 Category 1 (Applicable Classification Code)
- 5.2.2 Category 2 (Applicable Classification Code)
- 5.2.3 Category 3 (Applicable Classification Code)
- 5.2.4 Category 4 (Applicable Classification Code)
- 5.2.5 Category 5 (Applicable Classification Code)
- 5.3 Import Analysis – Segment
- 5.3.1 Category 1 (Applicable Classification Code)
- 5.3.2 Category 2 (Applicable Classification Code)
- 5.3.3 Category 3 (Applicable Classification Code)
- 5.3.4 Category 4 (Applicable Classification Code)
- 5.3.5 Category 5 (Applicable Classification Code)
- 5.4 Cross-Border Pricing & Transaction Benchmarks
- 5.4.1 Export Pricing – Segment & Country
- 5.4.2 Import Pricing – Segment & Source Country
- 5.4.3 Price Trends (2028)
- 5.5 Key Cross-Border Trade & Delivery Routes
- 5.5.1 Cross-Border Trade/Delivery Route 1
- 5.5.2 Cross-Border Trade/Delivery Route 2
- 5.5.3 Cross-Border Trade/Delivery Route 3
- 5.5.4 Cross-Border Trade/Delivery Route 4
- 5.5.5 Cross-Border Trade/Delivery Route 5
- 5.6 Trade Policy & Market Access Impact Assessment
- 5.6.1 Tariff & Non-Tariff Barriers
- 5.6.2 Regional Trade & Economic Integration Frameworks
- 5.6.3 Bilateral & Multilateral Trade Agreements
- 5.6.4 Cross-Border Operating, Licensing & Localization Requirements
Note: This chapter applies where cross-border trade or delivery is relevant to Legal Cannabis. Goods, services, and digital offerings are assessed using applicable classifications and transaction measures. Import-export volumes, trade balances, and route analyses are included only where meaningful to the market.
Chapter 6. Competitive Landscape & Company Benchmarking
- 6.1 Legal Cannabis Market Concentration & Structure
- 6.1.1 Herfindahl-Hirschman Index (HHI) – vs. 2028
- 6.1.2 Leading, Mid-Sized & Emerging Player Structure
- 6.1.3 Global, Regional & Local Player Dynamics
- 6.2 Legal Cannabis Market Share Analysis – 2028
- 6.2.1 Global Revenue Share by Company
- 6.2.2 Global Volume Share by Company (Volume Where Applicable)
- 6.2.3 Regional Revenue Share
- 6.2.4 Market Share Evolution ( vs. 2028)
- 6.2.5 Company Market Share by Key Segment
- 6.2.6 Company Market Share by Customer Group
- 6.3 Operating Scale, Capacity & Infrastructure Analysis
- 6.3.1 Global Operating Scale & Supply Capacity
- 6.3.2 Resource Utilization & Operating Efficiency
- 6.3.3 Output, Service Delivery & Activity Metrics
- 6.3.4 Operating Footprint & Infrastructure Map
- 6.3.5 Planned Operational & Capacity Expansion
- 6.4 Legal Cannabis Competitive Benchmarking Matrix
- 6.4.1 Revenue, Growth, Profitability & Operating Metric Comparison
- 6.4.2 Channel Revenue Mix
- 6.4.3 Geographic Revenue Exposure
- 6.4.4 R&D Intensity
- 6.4.5 Sustainability Maturity
- 6.5 Strategic Developments in Legal Cannabis (Last 24 Months)
- 6.5.1 Mergers, Acquisitions & Divestments
- 6.5.2 New Products, Services & Solutions in Legal Cannabis
- 6.5.3 Operational & Infrastructure Expansions
- 6.5.4 Strategic Alliances, Joint Ventures & Partnerships
- 6.5.5 Distribution Expansion & Market Entry
- 6.5.6 Sustainability & ESG Initiatives
- 6.6 Competitive Strategy Mapping
- 6.6.1 Leader, Challenger, Follower & Niche Classification
- 6.6.2 Pricing Strategy Comparison
- 6.6.3 Channel Strategy Matrix
Note: Strategic developments are included based on their materiality and the availability of reliable information.
Chapter 7. Global Legal Cannabis Market – By Sales & Delivery Channel
- 7.1 Segment Overview
- 7.1.1 Volume & Revenue Split by Channel (2028 & ) (Volume Where Applicable)
- 7.1.2 Channel Mix Evolution (the forecast period)
Chapter 8. Regional Market Analysis – Global Overview
- 8.1 Global Regional Overview
- 8.1.1 Regional Volume Share (Volume Where Applicable)
- 8.1.2 Regional Revenue Share
- 8.1.3 Regional Volume by Region (Volume Where Applicable)
- 8.1.4 Regional Revenue by Region
- 8.1.5 Regional Forecast Through the forecast period
- 8.2 Cross-Regional Segment Analysis
- 8.2.1 By Sales & Delivery Channel
- 8.2.2 By Competitive Positioning & Price Tier
Chapter 9. North America Legal Cannabis Market
- 9.1 United States
- 9.2 Canada
- 9.3 Mexico
Chapter 10. Europe Legal Cannabis Market
- 10.1 Germany
- 10.2 France
- 10.3 Italy
- 10.4 United Kingdom
- 10.5 Spain
- 10.6 Poland
- 10.7 Russia
- 10.8 Netherlands
- 10.9 Belgium
- 10.10 Sweden
- 10.11 Denmark
- 10.12 Norway
- 10.13 Rest of Europe
Chapter 11. Asia Pacific Legal Cannabis Market
- 11.1 China
- 11.2 India
- 11.3 Japan
- 11.4 South Korea
- 11.5 Thailand
- 11.6 Indonesia
- 11.7 Vietnam
- 11.8 Malaysia
- 11.9 Australia
- 11.10 Rest of Asia Pacific
Chapter 12. Latin America Legal Cannabis Market
- 12.1 Brazil
- 12.2 Argentina
- 12.3 Colombia
- 12.4 Chile
- 12.5 Rest of Latin America
Chapter 13. Middle East Legal Cannabis Market
- 13.1 Saudi Arabia
- 13.2 United Arab Emirates
- 13.3 Turkey
- 13.4 Israel
- 13.5 Iran
- 13.6 Rest of the Middle East
Chapter 14. Africa Legal Cannabis Market
- 14.1 South Africa
- 14.2 Egypt
- 14.3 Nigeria
- 14.4 Morocco
- 14.5 Rest of Africa
Chapter 15. Legal Cannabis Company Profiles
- 15.1 [Company 01]
- 15.1.1 Company Overview
- 15.1.2 Key Management Personnel
- 15.1.3 Products & Services Portfolio
- 15.1.4 Financial Performance
- 15.1.5 Key Market Focus & Geographic Presence
- 15.1.6 Recent Developments & Strategic Initiatives
Note: The company profile list is preliminary and may change based on research findings, market developments, data availability, and client requirements.
Chapter 16. Appendices
- Appendix A – List of Abbreviations & Acronyms
- Appendix B – Industry Classification Code Reference – Full Series
- Appendix C – Supply, Output & Operating Capacity Data Tables
- Appendix D – End-Use & Demand Base Tables
- Appendix E – Demand, Adoption & Usage Assumptions
- Appendix F – Pricing & Revenue Metric Reference Tables
- Appendix G – Company Operations & Infrastructure Database
- Appendix H – Cross-Border Trade & Activity Data Tables (Where Applicable)
- Appendix I – Regulatory Summary Tables
- Appendix J – Primary Research Participant List (Anonymized)
- Appendix K – Primary Research Questionnaire Framework
- Appendix L – Data Sources & Bibliography
- Appendix M – Market Size Divergence & Source Comparison
Chapter 17. Research Methodology
- 17.1 Research Framework & Philosophy
- 17.2 Secondary Research – Sources, Hierarchy & Data Extraction
- 17.3 Data Modeling – Bottom-Up & Top-Down Market Sizing
- 17.4 Primary Research – Stakeholder Framework, LOI & Sample Sizes
- 17.5 Forecast Methodology – Regression, Scenario & Sensitivity Analysis
- 17.6 Quality Control – Four-Layer Validation Framework
- 17.7 Limitations & Standard Assumptions
- 17.8 Disclaimer
